Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,318 public trials 1,292 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma

NCT03416933

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Centre Georges François Leclerc (CGFL) Dijon, France

Hôpital de Mercy Thionville, France

CHRU Nancy Vandœuvre-lès-Nancy, France

Institut de Cancérologie de Lorraine (ICL) Vandœuvre-lès-Nancy, France

View Trial Details

Completed

mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme

NCT02619864

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

QEII Health Sciences Centre Halifax, Nova Scotia, Canada

University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

NCT00053794

Conditions: Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +41 more
Locations: Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada

British Columbia Cancer Agency - Vancouver Island Cancer Centre Vancouver, British Columbia, Canada

Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada

Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada

View Trial Details

Completed

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00053781

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada

Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada

Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada

Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00514085

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada

BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View Trial Details

Completed

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors

NCT01419834

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

NCT00006734

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +8 more
Locations: Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Cancer Research Institute Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View all 239 locations

View Trial Details

Completed

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

NCT03581188

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Newcastle Skin Check Newcastle, New South Wales, Australia

Melanoma Institute Australia North Sydney, New South Wales, Australia

Royal Prince Alfred Hospital Sydney, New South Wales, Australia

View Trial Details

Completed

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

NCT03538587

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +24 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

NCT04351373

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +19 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions